Clearmind Medicine to Issue $2 Million in Convertible Debt Under Existing Agreement
Clearmind Medicine notified investors on October 16, 2026, of a $2 million convertible promissory note issuance under its existing $10 million program. The notes will generate $1.8 million in cash proceeds at 90% of principal value. Closing is expected on or before October 19, 2026. Disclaimer: This news brief was crea